Cargando…
Editorial: Current approaches to CRISPR/Cas9 delivery
Autores principales: | Uludağ, Hasan, Aliabadi, Hamidreza Montazeri, Gasiunas, Giedrius |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780433/ https://www.ncbi.nlm.nih.gov/pubmed/36568287 http://dx.doi.org/10.3389/fbioe.2022.1103007 |
Ejemplares similares
-
Prospects for RNAi Therapy of COVID-19
por: Uludağ, Hasan, et al.
Publicado: (2020) -
Targeting Cell Cycle Proteins in Breast Cancer Cells with siRNA by Using Lipid-Substituted Polyethylenimines
por: Parmar, Manoj B., et al.
Publicado: (2015) -
Delivering the CRISPR/Cas9 system for engineering gene therapies: Recent cargo and delivery approaches for clinical translation
por: Foley, Ruth A., et al.
Publicado: (2022) -
Calcium phosphate-based nanomedicine mediated CRISPR/Cas9 delivery for prostate cancer therapy
por: Wei, Chao-Gang, et al.
Publicado: (2022) -
CRISPR/Cas systems: Delivery and application in gene therapy
por: Huang, Jie, et al.
Publicado: (2022)